{
  "experiment_info": {
    "experiment_name": "paper_22_Discovering_Novel",
    "run_number": 9,
    "total_runs": 10,
    "timestamp": "20250623_220414",
    "run_start_time": "2025-06-24T00:02:11.191730",
    "run_end_time": "2025-06-24T00:02:42.988996"
  },
  "inputs": {
    "initial_description": {
      "timestamp": "2025-06-24T00:02:11.192729",
      "data": {
        "description": "Solid tumors must recruit new blood vessels for growth and maintenance. Discovering drugs that block this tumor-induced development of new blood vessels (angiogenesis) is an important approach in cancer treatment. However, the complexity of angiogenesis and the difficulty in implementing and evaluating rationally-designed treatments prevent the discovery of effective new therapies. This paper presents a massively parallel computational search-based approach for the discovery of novel potential cancer treatments using a high fidelity simulation of angiogenesis. Discovering new therapies is viewed as multi-objective combinatorial optimization over two competing objectives: minimizing the cost of developing the intervention while minimizing the oxygen provided to the cancer tumor by angiogenesis. Results show the effectiveness of the search process in finding interventions that are currently in use and more interestingly, discovering some new approaches that are counter intuitive yet effective."
      }
    }
  },
  "llm_responses": [
    {
      "step": "llm_response",
      "timestamp": "2025-06-24T00:02:24.636619",
      "prompt": "Original description: Solid tumors must recruit new blood vessels for growth and maintenance. Discovering drugs that block this tumor-induced development of new blood vessels (angiogenesis) is an important approach in cancer treatment. However, the complexity of angiogenesis and the difficulty in implementing and evaluating rationally-designed treatments prevent the discovery of effective new therapies. This paper presents a massively parallel computational search-based approach for the discovery of novel potential cancer treatments using a high fidelity simulation of angiogenesis. Discovering new therapies is viewed as multi-objective combinatorial optimization over two competing objectives: minimizing the cost of developing the intervention while minimizing the oxygen provided to the cancer tumor by angiogenesis. Results show the effectiveness of the search process in finding interventions that are currently in use and more interestingly, discovering some new approaches that are counter intuitive yet effective.\n\nClarifications provided: \n\n\n    Return ONLY a JSON object with ontology annotations. Format all IDs and terms exactly as specified in the system message.",
      "system_message": "You are a biological modeling expert. Create structured ontology annotations based on the provided information. \n    Include relevant Cell Ontology, GO, and MeSH terms where applicable.\n    Return ONLY a JSON object with categories for different ontology types.\n    \n    Format requirements:\n    1. Category names must be exact:\n       - \"CellOntology\" (not \"Cell Ontology\" or \"Cell  Ontology\")\n       - \"GeneOntology\" (not \"Gene Ontology\" or \"Gene  Ontology\")\n       - \"MeSH\" (not \"MeSH Terms\" or \"MeSH  Terms\")\n    \n    2. Ontology IDs must be exact without spaces:\n       - Cell Ontology: \"CL:0000000\" (not \"CL : 000 000 0\")\n       - Gene Ontology: \"GO:0000000\" (not \"GO : 000 000 0\")\n       - MeSH: \"D000000\" (not \"D 000 000\")\n    \n    3. Term names must be exact without extra spaces:\n       - \"Epithelial\" (not \"Ep ith elial\")\n       - \"Mesenchymal\" (not \"Mes ench ym al\")\n    \n    Example format:\n    {\n        \"CellOntology\": [\n            {\n                \"id\": \"CL:0000000\",\n                \"term\": \"Epithelial\"\n            }\n        ],\n        \"GeneOntology\": [\n            {\n                \"id\": \"GO:0000000\",\n                \"term\": \"Cell Division\"\n            }\n        ],\n        \"MeSH\": [\n            {\n                \"id\": \"D000000\",\n                \"term\": \"Cell Proliferation\"\n            }\n        ]\n    }\n    \n    Do not include any explanations or thinking process.",
      "response": "<think>\nOkay, let me start by breaking down the user's query. They want me to create structured ontology annotations based on the provided information about the research paper on tumor angiogenesis and computational drug discovery. The annotations need to include Cell Ontology, Gene Ontology (GO), and MeSH terms where applicable. The output must be a JSON object with exact category names and properly formatted IDs and terms.\n\nFirst, I need to understand the original description. The paper discusses tumor-induced angiogenesis, which is the process of tumors recruiting new blood vessels. The research uses a computational approach to find drugs that block angiogenesis. Key points here are angiogenesis, cancer treatment, computational methods, multi-objective optimization, and potential new therapies.\n\nNow, I need to map these concepts to the relevant ontologies. Let's start with Cell Ontology (CL). The main cell types involved in angiogenesis are endothelial cells, which form the blood vessels. There's also mention of epithelial and mesenchymal cells in the example, but I need to confirm if they're relevant here. The paper focuses on tumor-induced angiogenesis, so endothelial cells are definitely involved. The CL term for endothelial cell is CL:0000115. I should include that.\n\nNext, Gene Ontology (GO). Angiogenesis itself is a biological process, so the GO term for angiogenesis is GO:0001525. The paper also talks about blood vessel development, which is another process related to angiogenesis. The GO term for blood vessel morphogenesis is GO:0048514. Additionally, since the study uses computational methods for drug discovery, terms like \"response to drug\" (GO:0042493) might be relevant. However, I should check if the paper's focus on discovering drugs that block angiogenesis directly relates to these terms. Yes, because the interventions are drugs that affect the angiogenesis process, so response to drug applies here.\n\nFor MeSH terms, the main topics are Neoplasms (D009369), since the paper is about cancer tumors. Angiogenesis Inhibitors (D019379) are drugs that block angiogenesis, which is exactly what the research is targeting. Also, the computational approach involves combinatorial chemistry (D003019) for drug discovery. Another relevant term could be Drug Discovery (D000293), but I need to check the MeSH IDs. Yes, Drug Discovery is D000293. However, the example uses \"Angiogenesis Inhibitors\" and \"Drug Discovery\" which are both valid. The paper's use of combinatorial optimization in searching for treatments might relate to \"Combinatorial Chemistry Techniques\" (D003019). Also, \"Neovascularization, Pathologic\" (D054269) is a MeSH term for abnormal blood vessel growth, which is what happens in tumors. So including that would be appropriate.\n\nNow, I need to ensure all IDs and terms are correctly formatted. CellOntology category must have CL IDs, GeneOntology with GO IDs, and MeSH with D IDs. Also, check for exact term names without extra spaces. For example, \"Endothelial Cell\" not \"Endothelial cell\" or \"Endothelial-Cell\".\n\nPutting it all together:\n\nCellOntology:\n- Endothelial Cell (CL:0000115)\n\nGeneOntology:\n- Angiogenesis (GO:0001525)\n- Blood vessel morphogenesis (GO:0048514)\n- Response to drug (GO:0042493)\n\nMeSH:\n- Neoplasms (D009369)\n- Angiogenesis Inhibitors (D019379)\n- Combinatorial Chemistry Techniques (D003019)\n- Neovascularization, Pathologic (D054269)\n\nI should double-check each term's ID and ensure the spelling matches the ontology databases. For example, \"Neovascularization, Pathologic\" is the correct MeSH term, and the ID D054269 is accurate. Also, confirm that \"Response to drug\" is the exact term in GO. Yes, GO:0042493 is indeed \"response to drug\".\n\nNo other terms come to mind immediately. The paper doesn't mention specific cell types beyond endothelial cells in the context of angiogenesis. The therapies discussed are about inhibiting angiogenesis, so the MeSH terms selected cover the main aspects: the disease (neoplasms), the inhibitors, the computational method (combinatorial chemistry), and the pathological angiogenesis.\n\nSo the final JSON should list these terms under their respective categories with correct formatting.\n</think>\n\n{\n    \"CellOntology\": [\n        {\n            \"id\": \"CL:0000115\",\n            \"term\": \"Endothelial Cell\"\n        }\n    ],\n    \"GeneOntology\": [\n        {\n            \"id\": \"GO:0001525\",\n            \"term\": \"Angiogenesis\"\n        },\n        {\n            \"id\": \"GO:0048514\",\n            \"term\": \"Blood Vessel Morphogenesis\"\n        },\n        {\n            \"id\": \"GO:0042493\",\n            \"term\": \"Response to Drug\"\n        }\n    ],\n    \"MeSH\": [\n        {\n            \"id\": \"D009369\",\n            \"term\": \"Neoplasms\"\n        },\n        {\n            \"id\": \"D019379\",\n            \"term\": \"Angiogenesis Inhibitors\"\n        },\n        {\n            \"id\": \"D003019\",\n            \"term\": \"Combinatorial Chemistry Techniques\"\n        },\n        {\n            \"id\": \"D054269\",\n            \"term\": \"Neovascularization, Pathologic\"\n        }\n    ]\n}"
    },
    {
      "step": "llm_response",
      "timestamp": "2025-06-24T00:02:42.973949",
      "prompt": "Generate a valid CompuCell3D simulation file based on these ontology annotations.\n    Return ONLY the Python code:\n\n{'CellOntology': {'Endothelial Cell (CL:0000115)'}, 'GeneOntology': {'Response to Drug (GO:0042493)', 'Angiogenesis (GO:0001525)', 'Blood Vessel Morphogenesis (GO:0048514)'}, 'MeSH': {'Angiogenesis Inhibitors (D019379)', 'Combinatorial Chemistry Techniques (D003019)', 'Neovascularization, Pathologic (D054269)', 'Neoplasms (D009369)'}}",
      "system_message": "You are a CompuCell3D expert. Generate a valid CompuCell3D simulation file.\n    Return ONLY the Python code without any additional text, explanations, or thinking process.\n    The code must include:\n    1. Required imports (CompuCellSetup, steppables)\n    2. A proper simulation class that inherits from steppables.SteppableBasePy\n    3. Required methods (__init__, start, step)\n    4. Basic cell types and parameters based on the ontology annotations",
      "response": "<think>\nOkay, I need to generate a valid CompuCell3D simulation file based on the given ontology annotations. Let me start by recalling the structure of a typical CompuCell3D script. The user specified that the code must include required imports, a simulation class inheriting from SteppableBasePy, and the __init__, start, and step methods. Also, basic cell types and parameters based on the ontology provided.\n\nFirst, the imports. The standard ones are CompuCellSetup and the steppables module. So I'll import those.\n\nNext, the simulation class. It should inherit from steppables.SteppableBasePy. The class will need an __init__ method where I call the parent's __init__. The start method is where I'll initialize the simulation, probably setting up cells and parameters. The step method will handle actions each simulation step.\n\nLooking at the ontology annotations: CellOntology includes Endothelial Cell. GeneOntology terms are Response to Drug, Angiogenesis, Blood Vessel Morphogenesis. MeSH terms include Angiogenesis Inhibitors, Neoplasms, etc. So the simulation likely involves endothelial cells involved in angiogenesis, possibly with drug responses and tumor-related neovascularization.\n\nI need to define cell types. The main type here is Endothelial. Maybe also a Tumor cell type because of Neoplasms in MeSH. Angiogenesis inhibitors could be a chemical field affecting cell behaviors.\n\nIn the start method, I should set up the cell types. Use self.cellType to assign types. Also, set up a chemical field for the inhibitor. Maybe set up initial cells, like a tumor region and surrounding endothelial cells.\n\nFor parameters, adhesion energies, maybe chemotaxis towards a growth factor (for angiogenesis), and the inhibitor affecting motility or growth. In the step method, adjust cell behaviors based on the chemical fields, like chemotaxis or drug response.\n\nWait, in CompuCell3D, chemical fields are often handled via the XML, but maybe in the Python script, I can define them. Alternatively, use the steppable to modify cell properties. Also, cell division and death might be part of the response to drugs.\n\nSo, the code outline would be:\n\nImports: CompuCellSetup, steppables, and maybe some modules like random.\n\nDefine the Simulation class with __init__, start, step.\n\nIn start: initialize cell types (Endothelial, Tumor), setup initial cells (maybe a central tumor cluster and surrounding endothelial cells), set up chemical fields like inhibitor_conc.\n\nIn step: during each step, apply some logic, like cells chemotaxing towards a signal (for angiogenesis) or responding to the inhibitor (maybe reducing movement or proliferation).\n\nAlso, set up the volume and surface constraints for the cells, adhesion parameters between cell types.\n\nI need to make sure the code is valid. For example, in the start method, using self.pixel_to_cell to create cells. Maybe a tumor region in the center and endothelial cells around.\n\nIn the step method, check if the current step is a multiple of 100 to do something periodically, like print info.\n\nAlso, the simulation steps through time, applying these rules each step.\n\nPutting it all together, making sure to include all required parts. Now, write the code with proper syntax, ensuring that all methods are correctly defined, and parameters are set based on the ontology terms provided.\n</think>\n\n```python\nfrom pyvoxel.plugin import CompuCellSetup\nfrom pyvoxel.core import SteppableBasePy\nimport random\n\nclass AngiogenesisSimulation(SteppableBasePy):\n    def __init__(self, simulator, frequency=1):\n        super().__init__(simulator, frequency)\n        self.inhibitor_conc = 0.1\n        \n    def start(self):\n        self.setup_cell_types()\n        self.initialize_fields()\n        self.add_cells()\n        \n    def setup_cell_types(self):\n        self.endothelial_type = self.add_cell_type(\"Endothelial\")\n        self.tumor_type = self.add_cell_type(\"Tumor\")\n        self.set_volume_parameters(self.endothelial_type, target_volume=25, lambda_volume=2.0)\n        self.set_volume_parameters(self.tumor_type, target_volume=30, lambda_volume=1.5)\n        self.set_adhesion_parameters(self.endothelial_type, self.endothelial_type, 10)\n        self.set_adhesion_parameters(self.endothelial_type, self.tumor_type, 15)\n        self.set_chemotaxis_parameters(self.endothelial_type, \"VEGF\", 0.5)\n        \n    def initialize_fields(self):\n        self.add_chemical_field(\"VEGF\")\n        self.add_chemical_field(\"Inhibitor\")\n        self.set_constant_field(\"Inhibitor\", self.inhibitor_conc)\n        \n    def add_cells(self):\n        for _ in range(100):\n            x = random.randint(0, self.dim.x-1)\n            y = random.randint(0, self.dim.y-1)\n            self.add_cell(self.endothelial_type, x, y, 0)\n            \n        for _ in range(20):\n            x = random.randint(self.dim.x//2-10, self.dim.x//2+10)\n            y = random.randint(self.dim.y//2-10, self.dim.y//2+10)\n            self.add_cell(self.tumor_type, x, y, 0)\n            \n    def step(self, mcs):\n        if mcs % 100 == 0:\n            self.adjust_inhibitor_effect()\n            \n    def adjust_inhibitor_effect(self):\n        inhibitor_level = self.get_field_value(\"Inhibitor\", self.dim.x//2, self.dim.y//2, 0)\n        for cell in self.cell_list:\n            if cell.type == self.endothelial_type:\n                cell.lambda_volume = 2.0 + 0.1 * inhibitor_level\n\nCompuCellSetup.run()\n```"
    }
  ],
  "outputs": {},
  "metadata": {
    "experiment_model_type": "reasoning",
    "model_type": "reasoning",
    "model_name": "deepseek-ai/deepseek-r1",
    "thinking_process": "<think>\nOkay, I need to generate a valid CompuCell3D simulation file based on the given ontology annotations. Let me start by recalling the structure of a typical CompuCell3D script. The user specified that the code must include required imports, a simulation class inheriting from SteppableBasePy, and the __init__, start, and step methods. Also, basic cell types and parameters based on the ontology provided.\n\nFirst, the imports. The standard ones are CompuCellSetup and the steppables module. So I'll import those.\n\nNext, the simulation class. It should inherit from steppables.SteppableBasePy. The class will need an __init__ method where I call the parent's __init__. The start method is where I'll initialize the simulation, probably setting up cells and parameters. The step method will handle actions each simulation step.\n\nLooking at the ontology annotations: CellOntology includes Endothelial Cell. GeneOntology terms are Response to Drug, Angiogenesis, Blood Vessel Morphogenesis. MeSH terms include Angiogenesis Inhibitors, Neoplasms, etc. So the simulation likely involves endothelial cells involved in angiogenesis, possibly with drug responses and tumor-related neovascularization.\n\nI need to define cell types. The main type here is Endothelial. Maybe also a Tumor cell type because of Neoplasms in MeSH. Angiogenesis inhibitors could be a chemical field affecting cell behaviors.\n\nIn the start method, I should set up the cell types. Use self.cellType to assign types. Also, set up a chemical field for the inhibitor. Maybe set up initial cells, like a tumor region and surrounding endothelial cells.\n\nFor parameters, adhesion energies, maybe chemotaxis towards a growth factor (for angiogenesis), and the inhibitor affecting motility or growth. In the step method, adjust cell behaviors based on the chemical fields, like chemotaxis or drug response.\n\nWait, in CompuCell3D, chemical fields are often handled via the XML, but maybe in the Python script, I can define them. Alternatively, use the steppable to modify cell properties. Also, cell division and death might be part of the response to drugs.\n\nSo, the code outline would be:\n\nImports: CompuCellSetup, steppables, and maybe some modules like random.\n\nDefine the Simulation class with __init__, start, step.\n\nIn start: initialize cell types (Endothelial, Tumor), setup initial cells (maybe a central tumor cluster and surrounding endothelial cells), set up chemical fields like inhibitor_conc.\n\nIn step: during each step, apply some logic, like cells chemotaxing towards a signal (for angiogenesis) or responding to the inhibitor (maybe reducing movement or proliferation).\n\nAlso, set up the volume and surface constraints for the cells, adhesion parameters between cell types.\n\nI need to make sure the code is valid. For example, in the start method, using self.pixel_to_cell to create cells. Maybe a tumor region in the center and endothelial cells around.\n\nIn the step method, check if the current step is a multiple of 100 to do something periodically, like print info.\n\nAlso, the simulation steps through time, applying these rules each step.\n\nPutting it all together, making sure to include all required parts. Now, write the code with proper syntax, ensuring that all methods are correctly defined, and parameters are set based on the ontology terms provided.\n</think>",
    "cc3d_file_creation": {
      "python_code": "from cc3d.core.PySteppables import *\n\nfrom pyvoxel.plugin import CompuCellSetup\nfrom pyvoxel.core import SteppableBasePy\nimport random\n\nclass AngiogenesisSimulation(SteppableBasePy):\n    def __init__(self, simulator, frequency=1):\n        super().__init__(simulator, frequency)\n        self.inhibitor_conc = 0.1\n        \n    def start(self):\n        self.setup_cell_types()\n        self.initialize_fields()\n        self.add_cells()\n        \n    def setup_cell_types(self):\n        self.endothelial_type = self.add_cell_type(\"Endothelial\")\n        self.tumor_type = self.add_cell_type(\"Tumor\")\n        self.set_volume_parameters(self.endothelial_type, target_volume=25, lambda_volume=2.0)\n        self.set_volume_parameters(self.tumor_type, target_volume=30, lambda_volume=1.5)\n        self.set_adhesion_parameters(self.endothelial_type, self.endothelial_type, 10)\n        self.set_adhesion_parameters(self.endothelial_type, self.tumor_type, 15)\n        self.set_chemotaxis_parameters(self.endothelial_type, \"VEGF\", 0.5)\n        \n    def initialize_fields(self):\n        self.add_chemical_field(\"VEGF\")\n        self.add_chemical_field(\"Inhibitor\")\n        self.set_constant_field(\"Inhibitor\", self.inhibitor_conc)\n        \n    def add_cells(self):\n        for _ in range(100):\n            x = random.randint(0, self.dim.x-1)\n            y = random.randint(0, self.dim.y-1)\n            self.add_cell(self.endothelial_type, x, y, 0)\n            \n        for _ in range(20):\n            x = random.randint(self.dim.x//2-10, self.dim.x//2+10)\n            y = random.randint(self.dim.y//2-10, self.dim.y//2+10)\n            self.add_cell(self.tumor_type, x, y, 0)\n            \n    def step(self, mcs):\n        if mcs % 100 == 0:\n            self.adjust_inhibitor_effect()\n            \n    def adjust_inhibitor_effect(self):\n        inhibitor_level = self.get_field_value(\"Inhibitor\", self.dim.x//2, self.dim.y//2, 0)\n        for cell in self.cell_list:\n            if cell.type == self.endothelial_type:\n                cell.lambda_volume = 2.0 + 0.1 * inhibitor_level\n\nCompuCellSetup.run()",
      "output_file": "experiments\\batch_reasoning_20250623_220414\\paper_22_Discovering_Novel_20250623_220414\\run_9\\generated_cc3d_model.cc3d"
    }
  }
}